000 | 01168 a2200325 4500 | ||
---|---|---|---|
005 | 20250513070854.0 | ||
264 | 0 | _c19940203 | |
008 | 199402s 0 0 ger d | ||
022 | _a0036-7672 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTsakiris, D A | |
245 | 0 | 0 |
_a[Antiphospholipid syndrome: a new clinical entity? Part 2: pathophysiological aspects and treatment possibilities]. _h[electronic resource] |
260 |
_bSchweizerische medizinische Wochenschrift _cNov 1993 |
||
300 |
_a2183-90 p. _bdigital |
||
500 | _aPublication Type: English Abstract; Journal Article; Review | ||
650 | 0 | 4 |
_aAbortion, Habitual _ximmunology |
650 | 0 | 4 |
_aAntibodies, Antiphospholipid _ximmunology |
650 | 0 | 4 |
_aAntiphospholipid Syndrome _ximmunology |
650 | 0 | 4 |
_aArterial Occlusive Diseases _ximmunology |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIntracranial Embolism and Thrombosis _ximmunology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aPregnancy |
650 | 0 | 4 |
_aThrombosis _ximmunology |
700 | 1 | _ade Moerloose, P | |
773 | 0 |
_tSchweizerische medizinische Wochenschrift _gvol. 123 _gno. 46 _gp. 2183-90 |
|
999 |
_c8272071 _d8272071 |